These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8107057)

  • 1. Kinetics of appearance of intestinal lesions in mice mono-associated with a lethal or non-lethal strain of Clostridium difficile.
    Castex F; Jouvert S; Bastide M; Corthier G
    J Med Microbiol; 1994 Feb; 40(2):102-9. PubMed ID: 8107057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study.
    Castex F; Corthier G; Jouvert S; Elmer GW; Lucas F; Bastide M
    J Gen Microbiol; 1990 Jun; 136(6):1085-9. PubMed ID: 2200843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of toxins produced by various Clostridium difficile strains on cecum size reduction in gnotobiotic mice.
    Mahé S; Corthier G
    Can J Microbiol; 1988 Jul; 34(7):916-8. PubMed ID: 3143476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
    Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
    J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.
    Mahe S; Corthier G; Dubos F
    Infect Immun; 1987 Aug; 55(8):1801-5. PubMed ID: 3610315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxin and enterotoxin production by Clostridium difficile.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
    Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
    Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium.
    Feltis BA; Kim AS; Kinneberg KM; Lyerly DL; Wilkins TD; Erlandsen SL; Wells CL
    Arch Surg; 1999 Nov; 134(11):1235-41; discussion 1241-2. PubMed ID: 10555639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
    Feltis BA; Garni RM; Wells CL
    J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Clostridium difficile toxins from the small intestine and cecum of rabbits with naturally acquired enterotoxemia.
    Perkins SE; Fox JG; Taylor NS; Green DL; Lipman NS
    Lab Anim Sci; 1995 Aug; 45(4):379-84. PubMed ID: 7474876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomembranous colitis in Clostridium difficile-monoassociated rats.
    Czuprynski CJ; Johnson WJ; Balish E; Wilkins T
    Infect Immun; 1983 Mar; 39(3):1368-76. PubMed ID: 6840842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCR-ribotyping and pyrolysis mass spectrometry fingerprinting of environmental and hospital isolates of Clostridium difficile.
    Al-Saif NM; O'Neill GL; Magee JT; Brazier JS; Duerden BI
    J Med Microbiol; 1998 Feb; 47(2):117-21. PubMed ID: 9879953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
    Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
    Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
    Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
    J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains.
    Borriello SP; Barclay FE
    J Med Microbiol; 1985 Jun; 19(3):339-50. PubMed ID: 4009689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
    Torres JF
    J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.
    Siddiqui F; O'Connor JR; Nagaro K; Cheknis A; Sambol SP; Vedantam G; Gerding DN; Johnson S
    J Infect Dis; 2012 Jan; 205(1):128-33. PubMed ID: 22124129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Fanning S; Kyne L
    Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxin production by Clostridium difficile in a defined medium with limited amino acids.
    Yamakawa K; Kamiya S; Meng XQ; Karasawa T; Nakamura S
    J Med Microbiol; 1994 Nov; 41(5):319-23. PubMed ID: 7966203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation between isolation of bacteriophages from Clostridium difficile and cytotoxicity of the strains].
    Bernabeu A; Iniesta A; Martín Luengo F
    Enferm Infecc Microbiol Clin; 1991 May; 9(5):289-91. PubMed ID: 1954265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.